Home > Cashflow Statement > CIPLA

CIPLA
Cashflow Statement

CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Cashflow Statement History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax₹4,221 Cr₹3,675 Cr₹3,290 Cr₹2,178 Cr₹2,079 Cr
Adjustment ₹878 Cr₹967 Cr₹1,131 Cr₹1,366 Cr₹1,269 Cr
Changes In working Capital ₹-559 Cr₹-177 Cr₹372 Cr₹373 Cr₹-1,064 Cr
Cash Flow after changes in Working Capital ₹4,540 Cr₹4,465 Cr₹4,793 Cr₹3,917 Cr₹2,284 Cr
Cash Flow from Operating Activities ₹3,238 Cr₹3,326 Cr₹3,755 Cr₹3,068 Cr₹1,691 Cr
Cash Flow from Investing Activities ₹-2,389 Cr₹-1,872 Cr₹-2,387 Cr₹104 Cr₹-1,669 Cr
Cash Flow from Financing Activities ₹-958 Cr₹-1,600 Cr₹-1,240 Cr₹-2,949 Cr₹-349 Cr
Net Cash Inflow / Outflow ₹-109 Cr₹-146 Cr₹129 Cr₹224 Cr₹-326 Cr
Opening Cash & Cash Equivalents ₹658 Cr₹790 Cr₹649 Cr₹508 Cr₹853 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations ₹12 Cr₹13 Cr₹13 Cr₹10 Cr₹-19 Cr
Closing Cash & Cash Equivalent ₹561 Cr₹658 Cr₹790 Cr₹742 Cr₹508 Cr

Compare Cashflow Statement of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹112,059.0 Cr -1% -5.6% 54.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹363,535.0 Cr 0.9% -6.6% 58.8% Stock Analytics
DR REDDYS LABORATORIES ₹104,414.0 Cr 0.9% 2.2% 27.3% Stock Analytics
DIVIS LABORATORIES ₹103,845.0 Cr -2.2% 6.2% 21.2% Stock Analytics
ZYDUS LIFESCIENCES ₹98,676.3 Cr 2.8% -0.6% 96.2% Stock Analytics
MANKIND PHARMA ₹88,830.5 Cr -6.3% -5% NA Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

-1%

-5.6%

54.6%

SENSEX

-1.6%

-0.5%

19.8%


You may also like the below Video Courses